Child Neurologist, PhD
Inborn errors of endocrinology and metabolism comprise a large number of rare conditions with a collective incidence of around 1/1,500 newborns. Many disorders are treatable provided that a correct diagnosis can be established in time, and for many diseases novel therapies are being developed. This makes early diagnostics even more important and some of the diseases are included in neonatal screening programs (“PKU tests”). Without treatment, many of the conditions result in early death or severe irreversible handicaps. A major focus is on neurometabolic disorders. Another subgroup is disorders of sex development, where congenital adrenal hyperplasia (CAH) is the single most common disease.